...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New private placement

Seems a bit odd that PP would be done for a mere $50K CAD? 

Share
New Message
Please login to post a reply